Cellecho Inc., an Irvine biotech company, is seeking funding for its cell therapy technology that aims to make immunotherapy more accessible and safer for cancer patients. … Cellecho’s alternative is a microchip-based technology that reprograms cells. Its treatment can be manufactured in one day, versus the two weeks it takes to develop the standard cell therapy drug. “Our chips are highly scalable and offer consistent and precise cell engineering that minimizes manufacturing failure,” [postdoctoral scholar Mohammad] Aghaamoo said last month at a pitch event held at the University of California, Irvine. [Subscription required, you can request an electronic copy of the article by sending an email to communications@uci.edu.] Read More